Literature DB >> 12137965

Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide attenuate glutamate-induced nNOS activation and cytotoxicity.

Satomi Onoue1, Kosuke Endo, Takehiko Yajima, Kazuhisa Kashimoto.   

Abstract

Both vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) act as neurotransmitters in the central and peripheral nervous systems. Attention has been focused on these neuropeptides because among their numerous biological activities, they have been confirmed to show neuroprotective effects against ischemia and glutamate-induced cytotoxicity. It is well established that glutamate has excitatory effects on neuronal cells, and that excessive glutamate shows potent neurotoxicity, especially in neuronal nitric oxide synthase-containing neurons. Glutamate stimulates the production of nitric oxide (NO) in neurons, and the NO generated is tightly associated with the delayed death of neurons. We examined the effects of these neuropeptides on the glutamate-induced neural actions using PC12 cells, and we confirmed the important activities of PACAP/VIP on the production of NO as well as the delayed cell death stimulated by glutamate.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12137965     DOI: 10.1016/s0167-0115(02)00065-4

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  4 in total

1.  Neuroprotection by endogenous and exogenous PACAP following stroke.

Authors:  Yun Chen; Babru Samal; Carol R Hamelink; Charlie C Xiang; Yong Chen; Mei Chen; David Vaudry; Michael J Brownstein; John M Hallenbeck; Lee E Eiden
Journal:  Regul Pept       Date:  2006-10-04

2.  STC1 induction by PACAP is mediated through cAMP and ERK1/2 but not PKA in cultured cortical neurons.

Authors:  Yvonne Holighaus; Eberhard Weihe; Lee E Eiden
Journal:  J Mol Neurosci       Date:  2012-01       Impact factor: 3.444

Review 3.  Pituitary Adenylate Cyclase-Activating Polypeptide: A Promising Neuroprotective Peptide in Stroke.

Authors:  Yuanjian Fang; Reng Ren; Hui Shi; Lei Huang; Cameron Lenahan; Qin Lu; Lihui Tang; Yi Huang; Jiping Tang; Jianmin Zhang; John H Zhang
Journal:  Aging Dis       Date:  2020-12-01       Impact factor: 6.745

4.  PACAP-38 induces neuronal differentiation of human SH-SY5Y neuroblastoma cells via cAMP-mediated activation of ERK and p38 MAP kinases.

Authors:  T K Monaghan; C J Mackenzie; R Plevin; E M Lutz
Journal:  J Neurochem       Date:  2007-11-06       Impact factor: 5.372

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.